Intrathecal sICAM-1 production in multiple sclerosis Correlation with triple dose Gd-DTPA MRI enhancement and IgG index

Journal of Neurology

Volumn 252, Issue 2, 2005, Pages 146-150

  Acar, Göksemin ^a,b   Idiman, Fethi ^a   Kirkali, Güldal ^a   Özakbaş, Serkan ^a   Oktay, Gülgün ^a   Çakmakçi, Handan ^a   Idiman, Egemen ^a  

^a DOKUZ EYLUL UNIVERSITY   (Turkey)

^b NONE   (Turkey)

Author keywords

IgG index; MRI; Multiple sclerosis; sICAM; Triple dose gadolinium

Indexed keywords

BIOLOGICAL MARKER; GADOLINIUM PENTETATE; IMMUNOGLOBULIN G; INTERCELLULAR ADHESION MOLECULE 1;

ADULT; ARTICLE; BLOOD SAMPLING; CEREBROSPINAL FLUID ANALYSIS; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MALE; MULTIPLE SCLEROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN CEREBROSPINAL FLUID LEVEL; RADIATION DOSE; RELAPSE; REMISSION; STATISTICAL SIGNIFICANCE;

ADULT; DISEASE PROGRESSION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GADOLINIUM DTPA; HUMANS; IMAGE ENHANCEMENT; IMMUNOGLOBULIN G; IMMUNOPRECIPITATION; INTERCELLULAR ADHESION MOLECULE-1; MAGNETIC RESONANCE IMAGING; MALE; MULTIPLE SCLEROSIS; NEPHELOMETRY AND TURBIDIMETRY; SOLUBILITY; STATISTICS; STATISTICS, NONPARAMETRIC; TIME FACTORS;

EID: 15244340295     PISSN: 03405354     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00415-005-0618-1     Document Type: Article

References (18)

1. Bevilacqua MP (1993) Endothelialleukocyte adhesion molecules. Annu Rev Immunol 11:767-804
2. Dore-Duffy P, Newman W, Balabanov R, et al. (1995) Circulating soluble adhesion proteins in cerebrospinal fluid and serum of the patients with multiple sclerosis: correlation with clinical activity. Ann Neurol 37:55-62
3. Droogan AG, McMillan SA, Douglas JP, Hawkins SA (1996) Serum and cerebrospinal fluid levels of soluble adhesion molecules in multiple sclerosis: predominant intrathecal release of vascular cell adhesion molecule-1. J Neuroimmunol 64:185-191
4. Gearing JH, Newman W (1993) Circulating adhesion molecules in disease. Immunol Today 14:506-507
5. Giovannoni G, Lai M, Thorpe J, Kidd D, Chamoun V, Thompson AJ, Miller DH, Feldmann M, Thompson EJ (1997) Longitudinal study of soluble adhesion molecules in multiple sclerosis: correlation with gadolinium enhanced magnetic resonance imaging. Neurology 48:1557-1565
6. Hartung HP, Michels M, Reiners K, Seeldrayers P, Archelos JJ, Toyka KV (1993) Soluble ICAM-1 serum levels in multiple sclerosis and viral encephalitis. Neurology 43:2331-2335
7. Hartung HP, Reiners K, Archelos JJ, Michels M, Seeldrayers P, Heidenreich F, Pflughaupt KW, Toyka KV (1995) Circulating adhesion molecules and tumor necrosis factor receptor in multiple sclerosis: correlation with magnetic resonance imaging. Ann Neurol 38(2):186-193
8. Jander S, Heidenreich F, Stoll G (1993) Serum and CSF levels of soluble Intercellular adhesion molecule-1 (ICAM-1) in inflammatory neurologic diseases. Neurology 43:1809-1813
9. Kurtzke JF (1983) Rating neurological impairment in multiple sclerosis: An expanded disability status scale (EDSS). Neurology 33:1444-1452
10. McDonald WI, Combston A, Edan G, Goodkin D, Hartung HP, Lublin FD, McFarland HF, Paty DW, Polman CH, Reingold SC, Sandberg-Wollheim M, Sibley W, Thompson A, van den Noort S, Weinshenker BY, Wolinsky JS (2001) Recommended diagnostic criteria for multiple sclerosis: Guidelines from the international panel on the diagnosis of multiple sclerosis. Ann Neurol 50: 121-127
11. McDonnell GV, McMillan SA, Douglas JP, Droogan AG, Hawkins SA (1998) Raised CSF levels of soluble adhesion molecules across the clinical spectrum of multiple sclerosis. J Neuroimmunol 85:186-192
12. Petersen AA, Sellebjerg F, Freeriksen J, Diesen J, Vejlsgaard GL (1998) Soluble ICAM-1, demyelination and inflammation in multiple sclerosis and acute optic neuritis. J Neuroimmunol 88: 120-127
13. Rieckmann P, Altenhofen B, Riegel A, Baudewig J, Felgenhauer K (1997) Soluble adhesion molecules (sVCAM-1 and sICAM-1) in cerebrospinal fluid and serum correlate with MRI activity in multiple sclerosis. Ann Neurol 41: 326-333
14. Rieckmann P, Martin S, Weichselbraun I, Albrecht M, Kitze B, Weber T, Tumani H, Broocks A, Luer W, Helwig A (1994) Serial analysis of circulating adhesion molecule and the TNF receptor in serum of patients with multiple sclerosis: cICAM-1 is an indicator for relapse. Neurology 44:2367-2372
15. Sharief MK, Noori MA, Ciardi M, Cirelli A, Thompson EJ (1993) Increased levels of circulating ICAM-1 in serum and cerebrospinal fluid of patients with active multiple sclerosis: correlation with TNF-α and blood brain barrier damage. J Neuroimmunol 43:15-22
16. Trojano M, Avolio C, Simone IL, Defazio G, Manzari C, de Robertis F, Calo A, Livrea P (1996) Soluble intercellular adhesion molecule-1 in serum and cerebrospinal fluid of clinically active relapsing-remitting multiple sclerosis: correlation with Gd-DTPA magnetic resonance imaging enhancement and cerebrospinal fluid findings. Neurology 47:1535-1541
17. Tsukada N, Miyagi K, Matsuda M, Yanagisawa N (1993) Increased levels of circulating intercellular adhesion molecule-1 in multiple sclerosis and human T-lymphotropic virus type-1 associated myelopathy. Ann Neurol 33:646-649
18. Vachula M, Van Epps DE (1992) In vitro models of lymphocyte transendothelial migration. Invasion Metastasis 12:66-81